Incidence of upgrading and upstaging in patients with low-volume gleason score 3+4 prostate cancers at biopsy: Finding a new group eligible for active surveillance

Hee Jung Park, Yun Sok Ha, Sung Yul Park, Yong Tae Kim, Tchun Yong Lee, Jeong Hyun Kim, Dong Hyeon Lee, Wun Jae Kim, Isaac Yi Kim

    Research output: Contribution to journalArticlepeer-review

    9 Scopus citations

    Abstract

    Introduction: The aim of this study was to identify patients with low-volume Gleason score 3+4 (GS3+4) prostate cancer (PCa) who may be candidates for active surveillance (AS) by analyzing the incidence of upgrading and upstaging following radical prostatectomy (RP). Patients and Methods: Of 907 patients who underwent RP at our institute over the last 5 years, 66 men diagnosed with low-volume GS3+4 PCa at needle biopsy were identified. The incidence of upstaging and upgrading was assessed. Results: The overall rate of upgrading and upstaging was 31.8 and 25.6%, respectively. Preoperative PSA levels were significantly higher in patients who were upgraded (p = 0.015). The optimal preoperative PSA cutoff level for the prediction of upgrading was 4.73 ng/ml (sensitivity 85.7%, specificity 57.8%). Patients with <15% of maximum cores positive had significantly lower upstaging rate than those with >15% of maximum cores positive (p = 0.035). Clinical stage and number of positive cores had marginal association with upgrading and upstaging statistically (p = 0.061 and 0.081, respectively). Conclusions: In patients with low-volume GS3+4 PCa at biopsy, underestimation may be effectively avoided when we select patients with PSA <4.73 and % maximum cancer involvement on positive cores <15%.

    Original languageEnglish (US)
    Pages (from-to)301-305
    Number of pages5
    JournalUrologia Internationalis
    Volume90
    Issue number3
    DOIs
    StatePublished - 2013

    ASJC Scopus subject areas

    • Urology

    Keywords

    • Active surveillance
    • Gleason score 3+4
    • Prostate cancer
    • Radical prostatectomy

    Fingerprint

    Dive into the research topics of 'Incidence of upgrading and upstaging in patients with low-volume gleason score 3+4 prostate cancers at biopsy: Finding a new group eligible for active surveillance'. Together they form a unique fingerprint.

    Cite this